Involvement of T Cells in Enhanced Resistance to Klebsiella pneumoniae Septicemia in Mice Treated with Liposome-Encapsulated Muramyl Tripeptide Phosphatidylethanolamine or Gamma Interferon

Samankaltaisia teoksia

• Treatment of Klebsiella pneumoniae septicemia in normal and leukopenic mice by liposome-encapsulated muramyl tripeptide phosphatidylethanolamide.
  Tekijä: Melissen, P M, et al.
  Julkaistu: (1994)
• Free versus liposome-encapsulated muramyl tripeptide phosphatidylethanolamide in treatment of experimental Klebsiella pneumoniae infection.
  Tekijä: Melissen, P M, et al.
  Julkaistu: (1992)
• Roles of peripheral leukocytes and tissue macrophages in antibacterial resistance induced by free or liposome-encapsulated muramyl tripeptide phosphatidylethanolamide.
  Tekijä: Melissen, P M, et al.
  Julkaistu: (1992)
• Beneficial effect of liposome-encapsulated muramyl tripeptide in experimental septicemia in a porcine model.
  Tekijä: Izbicki, J R, et al.
  Julkaistu: (1991)
• Therapy of human ovarian cancer xenografts with intraperitoneal liposome encapsulated muramyl-tripeptide phosphoethanolamine (MTP-PE) and recombinant GM-CSF.
  Tekijä: Malik, S. T., et al.
  Julkaistu: (1991)